S. An, M. A. Dickens, T. Bleu, O. G. Hallmark, and E. J. Goetzl, Molecular Cloning of the Human Edg2 Protein and Its Identification as a Functional Cellular Receptor for Lysophosphatidic Acid, Biochemical and Biophysical Research Communications, vol.231, issue.3, pp.619-622, 1997.
DOI : 10.1006/bbrc.1997.6150

S. An, T. Bleu, O. G. Hallmark, and E. J. Goetzl, Characterization of a Novel Subtype of Human G Protein-coupled Receptor for Lysophosphatidic Acid, Journal of Biological Chemistry, vol.273, issue.14, pp.7906-7910, 1998.
DOI : 10.1074/jbc.273.14.7906

K. Bandoh, J. Aoki, H. Hosono, S. Kobayashi, T. Kobayashi et al., Molecular Cloning and Characterization of a Novel Human G-protein-coupled Receptor, EDG7, for Lysophosphatidic Acid, Journal of Biological Chemistry, vol.274, issue.39, pp.27776-27785, 1999.
DOI : 10.1074/jbc.274.39.27776

K. Noguchi, S. Ishii, and T. Shimizu, Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg Family, Journal of Biological Chemistry, vol.278, issue.28, pp.25600-25606, 2003.
DOI : 10.1074/jbc.M302648200

T. M. Mcintyre, A. V. Pontsler, A. R. Silva, A. St-hilaire, Y. Xu et al., Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPAR?? agonist, Proceedings of the National Academy of Sciences, vol.287, issue.23, pp.131-136, 2003.
DOI : 10.1001/jama.287.23.3081

W. H. Moolenaar, Development of Our Current Understanding of Bioactive Lysophospholipids, Annals of the New York Academy of Sciences, vol.140, issue.1, pp.1-10, 2000.
DOI : 10.1111/j.1749-6632.2000.tb06532.x

G. B. Mills and W. H. Moolenaar, The emerging role of lysophosphatidic acid in cancer, Nature Reviews Cancer, vol.3, issue.8, pp.582-591, 2003.
DOI : 10.1038/nrc1143

Y. Xu, Z. Shen, D. W. Wiper, M. Wu, R. E. Morton et al., Lysophosphatidic Acid as a Potential Biomarker for Ovarian and Other Gynecologic Cancers, JAMA, vol.280, issue.8, pp.719-723, 1998.
DOI : 10.1001/jama.280.8.719

I. Pecheur, O. Peyruchaud, C. M. Serre, J. Guglielmi, C. Voland et al., Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone, Faseb J, vol.16, pp.1266-1268, 2002.

E. Camerer, A. A. Qazi, D. N. Duong, I. Cornelissen, R. Advincula et al., Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis, Blood, vol.104, issue.2, pp.397-401, 2004.
DOI : 10.1182/blood-2004-02-0434

G. Mundy, B. Oyojobi, K. Taraianedes, S. Dallas, C. et al., Cytokines and bone remodeling, pp.373-403, 2001.
DOI : 10.1016/b978-0-12-375098-3.50019-6

J. De-la-mata, H. L. Uy, T. A. Guise, B. Story, B. F. Boyce et al., Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo., Journal of Clinical Investigation, vol.95, issue.6, pp.2846-2852, 1995.
DOI : 10.1172/JCI117990

M. S. Bendre, D. Gaddy-kurten, T. Mon-foote, N. S. Akel, R. A. Skinner et al., Expression of interleukin 8 and not parathyroid hormonerelated protein by human breast cancer cells correlates with bone metastasis in vivo, Cancer Res, vol.62, pp.5571-5579, 2002.

M. Umezu-goto, Y. Kishi, A. Taira, K. Hama, N. Dohmae et al., Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production, The Journal of Cell Biology, vol.1, issue.2, pp.227-233, 2002.
DOI : 10.1016/S0960-9822(98)70157-5

K. Hama, J. Aoki, M. Fukaya, Y. Kishi, T. Sakai et al., Lysophosphatidic Acid and Autotaxin Stimulate Cell Motility of Neoplastic and Non-neoplastic Cells through LPA1, Journal of Biological Chemistry, vol.279, issue.17, pp.17634-17639, 2004.
DOI : 10.1074/jbc.M313927200

S. Karpatkin, E. Pearlstein, C. Ambrogio, and B. S. Coller, Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo., Journal of Clinical Investigation, vol.81, issue.4, pp.1012-1019, 1988.
DOI : 10.1172/JCI113411

B. Felding-habermann, T. E. O-'toole, J. W. Smith, E. Fransvea, Z. M. Ruggeri et al., Integrin activation controls metastasis in human breast cancer, Proceedings of the National Academy of Sciences, vol.91, issue.24, pp.1853-1858, 2001.
DOI : 10.1073/pnas.91.24.11413

P. Carmeliet and R. K. Jain, Angiogenesis in cancer and other diseases, Nature, vol.407, issue.6801, pp.249-257, 2000.
DOI : 10.1038/35025220

M. Trikha and M. T. Nakada, Platelets and Cancer: Implications for Antiangiogenic Therapy, Seminars in Thrombosis and Hemostasis, vol.28, issue.1, pp.39-44, 2002.
DOI : 10.1055/s-2002-20563

C. Belloc, H. Lu, C. Soria, R. Fridman, Y. Legrand et al., The effect of platelets on invasiveness and protease production of human mammary tumor cells, International Journal of Cancer, vol.49, issue.3, 1995.
DOI : 10.1002/ijc.2910600324

O. Peyruchaud, C. Serre, R. Nicamhlaoibh, P. Fournier, C. et al., Angiostatin Inhibits Bone Metastasis Formation in Nude Mice through a Direct Anti-osteoclastic Activity, Journal of Biological Chemistry, vol.278, issue.46, pp.45826-45832, 2003.
DOI : 10.1074/jbc.M309024200

T. J. Martin, Manipulating the environment of cancer cells in bone: a novel therapeutic approach, Journal of Clinical Investigation, vol.110, issue.10, pp.1399-1401, 2002.
DOI : 10.1172/JCI0217124

O. Peyruchaud and D. F. Mosher, Differential stimulation of signaling pathways initiated by Edg-2 in response to lysophosphatidic acid or sphingosine-1-phosphate, Cellular and Molecular Life Sciences, vol.57, issue.7, 2000.
DOI : 10.1007/PL00000747